Replies to post #2278 on Skye Bioscience Inc (SKYE)

[AntonChigurh]

Vinpat is a smart guy.

Also, from what I gathered from a lecture by Dr. ElSohly, every plant has a different genetic profile. While obviously they will be similar, I'm not sure how your grow can meet dosage consistency requirements. ElSohly said you literally have to clone one plant over and over to deliver the exact same combination of whatever strain/combination of cannibinoids. Seems time and capital consuming.

Even in a interview, the TBP ceo admits 90+ percent of doctors are not going to prescribe a plant, or something derived from a plant.

So, ya, not sure why GW is so insistent on their GMP grows for their drugs. NMUS and ZYNE seem to have the right idea, both in terms of product consistent and cost of production.

[nonewname1]

I agree on Tetra, thanks again for the response.